News
PGNY
18.12
+1.06%
0.19
Why Progyny (PGNY) Is Up 8.5% After Launching Progyny Select And Proposing Governance Changes - And What's Next
Simply Wall St · 1d ago
Progyny expands access to fertility, women’s health with Progyny Select
TipRanks · 1d ago
Progyny Launches Progyny Select, The Industry's First Fully Insured, Comprehensive Supplemental Fertility And Family Building Plan
Benzinga · 1d ago
Progyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan
Barchart · 2d ago
Weekly Report: what happened at PGNY last week (0406-0410)?
Weekly Report · 4d ago
2 Reasons to Sell PGNY and 1 Stock to Buy Instead
Barchart · 04/08 04:46
Quant check on insurer stocks as Medicare Advantage rate boost drives gains
Seeking Alpha · 04/07 06:35
Weekly Report: what happened at PGNY last week (0330-0403)?
Weekly Report · 04/06 09:20
A Look At Progyny (PGNY) Valuation After A Steep Three Month Share Price Pullback
Simply Wall St · 04/04 14:17
Progyny hosts webinar on fertility and family-building options, mental health support
Reuters · 04/03 16:57
Is Progyny (PGNY) Pricing Make Sense After Prolonged Share Price Slump?
Simply Wall St · 04/03 05:28
Progyny to join NASDAQ closing bell ceremony for infertility awareness week
Reuters · 04/01 13:23
Progyny Commemorates 10 Years of Redefining Women’s Health and Family Building Care
Barchart · 04/01 08:23
Progyny announces annual shareholder meeting via preliminary proxy statement
Reuters · 03/31 20:43
Weekly Report: what happened at PGNY last week (0323-0327)?
Weekly Report · 03/30 09:20
Weekly Report: what happened at PGNY last week (0316-0320)?
Weekly Report · 03/23 09:19
Progyny Price Target Cut to $23.00/Share From $29.00 by Barclays
Dow Jones · 03/20 13:38
Progyny Is Maintained at Overweight by Barclays
Dow Jones · 03/20 13:38
Barclays Maintains Overweight on Progyny, Lowers Price Target to $23
Benzinga · 03/20 13:28
PROGYNY <PGNY.O>: BARCLAYS CUTS TARGET PRICE TO $23 FROM $29
Reuters · 03/20 10:13
More
Webull provides a variety of real-time PGNY stock news. You can receive the latest news about Progyny, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About PGNY
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.